Found: 56
Select item for more details and to access through your institution.
Arsenic trioxide inhibits nuclear receptor function via SEK1/JNK-mediated RXRalpha phosphorylation.
- Published in:
- 2005
- By:
- Publication type:
- journal article
A phase-I study of lapatinib in combination with foretinib, a c-MET, AXL and vascular endothelial growth factor receptor inhibitor, in human epidermal growth factor receptor 2 (HER-2)-positive metastatic breast cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Adverse events associated with immune checkpoint inhibitor treatment for cancer.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Real-World Outcomes of Incurable Cancer Patients Treated with Unlisted Anticancer Treatments in an Academic Center in Quebec, Canada.
- Published in:
- Current Oncology, 2024, v. 31, n. 10, p. 5908, doi. 10.3390/curroncol31100440
- By:
- Publication type:
- Article
Antitumor effects of doxorubicin in combination with anti-epidermal growth factor receptor monoclonal antibodies.
- Published in:
- 1993
- By:
- Publication type:
- journal article
Novel Retinoic Acid Receptor-α Transcripts in Acute Promyelocytic Leukemia Responsive to All-trans-Retinoic Acid.
- Published in:
- JNCI: Journal of the National Cancer Institute, 1990, v. 82, n. 24, p. 1932
- By:
- Publication type:
- Article
A Non-Hazardous Deparaffinization Protocol Enables Quantitative Proteomics of Core Needle Biopsy-Sized Formalin-Fixed and Paraffin-Embedded (FFPE) Tissue Specimens.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 8, p. 4443, doi. 10.3390/ijms23084443
- By:
- Publication type:
- Article
The MNK1/2-eIF4E Axis as a Potential Therapeutic Target in Melanoma.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 11, p. 4055, doi. 10.3390/ijms21114055
- By:
- Publication type:
- Article
The eukaryotic translation initiation factor eIF4E harnesses hyaluronan production to drive its malignant activity.
- Published in:
- eLife, 2017, p. 1, doi. 10.7554/eLife.29830.001
- By:
- Publication type:
- Article
Retinoic acid modulates chromatin to potentiate tumor necrosis factor alpha signaling on the DIF2 promoter.
- Published in:
- Nucleic Acids Research, 2008, v. 36, n. 2, p. 435
- By:
- Publication type:
- Article
Author Correction: PD-L1 blockade in combination with inhibition of MAPK oncogenic signaling in patients with advanced melanoma.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Tunable PhenoCycler imaging of the murine pre-clinical tumour microenvironments.
- Published in:
- Cell & Bioscience, 2024, v. 14, n. 1, p. 1, doi. 10.1186/s13578-024-01199-4
- By:
- Publication type:
- Article
All-trans retinoic acid for acute promyelocytic leukemia. Results of the New York Study.
- Published in:
- 1994
- By:
- Publication type:
- journal article
Management of Pyrexia Associated with the Combination of Dabrafenib and Trametinib: Canadian Consensus Statements.
- Published in:
- Current Oncology, 2021, v. 28, n. 5, p. 3537, doi. 10.3390/curroncol28050304
- By:
- Publication type:
- Article
Correction to: CXCR2 antagonist navarixin in combination with pembrolizumab in select advanced solid tumors: a phase 2 randomized trial.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
CXCR2 antagonist navarixin in combination with pembrolizumab in select advanced solid tumors: a phase 2 randomized trial.
- Published in:
- Investigational New Drugs, 2024, v. 42, n. 1, p. 145, doi. 10.1007/s10637-023-01410-2
- By:
- Publication type:
- Article
Phase I study of daily and weekly regimens of the orally administered MDM2 antagonist idasanutlin in patients with advanced tumors.
- Published in:
- Investigational New Drugs, 2021, v. 39, n. 6, p. 1587, doi. 10.1007/s10637-021-01141-2
- By:
- Publication type:
- Article
A phase 1 study of the MDM2 antagonist RO6839921, a pegylated prodrug of idasanutlin, in patients with advanced solid tumors.
- Published in:
- Investigational New Drugs, 2020, v. 38, n. 4, p. 1156, doi. 10.1007/s10637-019-00869-2
- By:
- Publication type:
- Article
Analysis of Geographic and Environmental Factors and Their Association with Cutaneous Melanoma Incidence in Canada.
- Published in:
- Dermatology (10188665), 2022, v. 238, n. 6, p. 1006, doi. 10.1159/000524949
- By:
- Publication type:
- Article
Arsenic Trioxide Overcomes Rapamycin-Induced Feedback Activation of AKT and ERK Signaling to Enhance the Anti-Tumor Effects in Breast Cancer.
- Published in:
- PLoS ONE, 2013, v. 8, n. 12, p. 1, doi. 10.1371/journal.pone.0085995
- By:
- Publication type:
- Article
RIG-I Is Required for the Inhibition of Measles Virus by Retinoids.
- Published in:
- PLoS ONE, 2011, v. 6, n. 7, p. 1, doi. 10.1371/journal.pone.0022323
- By:
- Publication type:
- Article
Vorinostat Induces Reactive Oxygen Species and DNA Damage in Acute Myeloid Leukemia Cells.
- Published in:
- PLoS ONE, 2011, v. 6, n. 6, p. 1, doi. 10.1371/journal.pone.0020987
- By:
- Publication type:
- Article
Pembrolizumab plus epacadostat in patients with recurrent/metastatic head and neck squamous cell carcinoma (KEYNOTE-669/ECHO-304): a phase 3, randomized, open-label study.
- Published in:
- BMC Cancer, 2024, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-11316-0
- By:
- Publication type:
- Article
Arsenic trioxide as an inducer of apoptosis and loss of PML/RAR alpha protein in acute promyelocytic leukemia cells.
- Published in:
- 1998
- By:
- Publication type:
- journal article
Retinoic acid targets DNA-methyltransferases and histone deacetylases during APL blast differentiation in vitro and in vivo.
- Published in:
- Oncogene, 2005, v. 24, n. 11, p. 1820, doi. 10.1038/sj.onc.1208286
- By:
- Publication type:
- Article
Retinoic acid mediates degradation of IRS-1 by the ubiquitin-proteasome pathway, via a PKC-dependant mechanism.
- Published in:
- Oncogene, 2004, v. 23, n. 57, p. 9269, doi. 10.1038/sj.onc.1208104
- By:
- Publication type:
- Article
Nuclear insulin receptor substrate 1 interacts with estrogen receptoraat ERE promoters.
- Published in:
- Oncogene, 2004, v. 23, n. 45, p. 7517, doi. 10.1038/sj.onc.1208014
- By:
- Publication type:
- Article
Enhanced retinoid-induced apoptosis of MDA-MB-231 breast cancer cells by PKC inhibitors involves activation of ERK.
- Published in:
- Oncogene, 2004, v. 23, n. 42, p. 7053, doi. 10.1038/sj.onc.1207956
- By:
- Publication type:
- Article
Retinoic acid-induced growth arrest of MCF-7 cells involves the selective regulation of the IRS-1/PI 3-kinase/AKT pathway.
- Published in:
- Oncogene, 2003, v. 22, n. 22, p. 3353, doi. 10.1038/sj.onc.1206485
- By:
- Publication type:
- Article
Differentiation induction as a treatment for hematologic malignancies.
- Published in:
- Oncogene, 2002, v. 21, n. 21, p. 3496, doi. 10.1038/sj.onc.1205328
- By:
- Publication type:
- Article
Targeting the mTOR pathway uncouples the efficacy and toxicity of PD-1 blockade in renal transplantation.
- Published in:
- Nature Communications, 2019, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41467-019-12628-1
- By:
- Publication type:
- Article
Assessing Skin Cancer Risk Factors, Sun Safety Behaviors and Melanoma Concern in Atlantic Canada: A Comprehensive Survey Study.
- Published in:
- Cancers, 2023, v. 15, n. 15, p. 3753, doi. 10.3390/cancers15153753
- By:
- Publication type:
- Article
Defining the Criteria for Reflex Testing for BRAF Mutations in Cutaneous Melanoma Patients.
- Published in:
- Cancers, 2021, v. 13, n. 9, p. 2282, doi. 10.3390/cancers13092282
- By:
- Publication type:
- Article
The emerging role of retinoids and retinoic acid metabolism blocking agents in the treatment of cancer.
- Published in:
- 1998
- By:
- Publication type:
- journal article
Suramin for germ cell tumors. In vitro growth inhibition and results of a phase II trial.
- Published in:
- 1993
- By:
- Publication type:
- journal article
Phase I and pharmacokinetic study of Bay 38-3441, a camptothecin glycoconjugate, administered as a 30-minute infusion daily for five days every 3 weeks in patients with advanced solid malignancies.
- Published in:
- Investigational New Drugs, 2005, v. 23, n. 5, p. 455, doi. 10.1007/s10637-005-2905-1
- By:
- Publication type:
- Article
A phase II trial of ZD1839 (Iressa™) 750 mg per day, an oral epidermal growth factor receptor-tyrosine kinase inhibitor, in patients with metastatic colorectal cancer.
- Published in:
- Investigational New Drugs, 2005, v. 23, n. 2, p. 165, doi. 10.1007/s10637-005-5862-9
- By:
- Publication type:
- Article
Predicted long‐term impact of COVID‐19 pandemic‐related care delays on cancer mortality in Canada.
- Published in:
- International Journal of Cancer, 2022, v. 150, n. 8, p. 1244, doi. 10.1002/ijc.33884
- By:
- Publication type:
- Article
Evaluation of denaturing high-performance liquid chromatography as a rapid detection method for identification of epidermal growth factor receptor mutations in nonsmall-cell lung cancer.
- Published in:
- Cancer (0008543X), 2006, v. 107, n. 12, p. 2858, doi. 10.1002/cncr.22331
- By:
- Publication type:
- Article
Retinoids inhibit measles virus through a type I IFN-dependent bystander effect.
- Published in:
- FASEB Journal, 2009, v. 23, n. 9, p. 3203, doi. 10.1096/fj.09-129288
- By:
- Publication type:
- Article
The Role of eIF4E in Response and Acquired Resistance to Vemurafenib in Melanoma.
- Published in:
- Journal of Investigative Dermatology, 2015, v. 135, n. 5, p. 1368, doi. 10.1038/jid.2015.11
- By:
- Publication type:
- Article
The impact of lag time to cancer diagnosis and treatment on clinical outcomes prior to the COVID-19 pandemic: A scoping review of systematic reviews and meta-analyses.
- Published in:
- eLife, 2023, p. 1, doi. 10.7554/eLife.81354
- By:
- Publication type:
- Article
The Pharmacokinetics and Pharmacodynamics of Zoledronic Acid in Cancer Patients with Varying Degrees of Renal Function.
- Published in:
- Journal of Clinical Pharmacology, 2003, v. 43, n. 2, p. 154, doi. 10.1177/0091270002239824
- By:
- Publication type:
- Article
Insulin-like growth factors modulate the growth inhibitory effects of retinoic acid on MCF-7 breast cancer cells.
- Published in:
- Journal of Cellular Physiology, 1995, v. 165, n. 1, p. 212, doi. 10.1002/jcp.1041650124
- By:
- Publication type:
- Article
Molecular cytogenetics of the acute promyelocytic leukemia-derived cell line NB4 and of four all-trans retinoic acid-resistant subclones.
- Published in:
- Genes, Chromosomes & Cancer, 2002, v. 35, n. 3, p. 261, doi. 10.1002/gcc.10117
- By:
- Publication type:
- Article
The sonic hedgehog factor GLI1 imparts drug resistance through inducible glucuronidation.
- Published in:
- Nature, 2014, v. 511, n. 7507, p. 90, doi. 10.1038/nature13283
- By:
- Publication type:
- Article
The Rossy Cancer Network: Building platforms for advancing knowledge in cancer care quality improvement.
- Published in:
- Oncology Exchange, 2015, v. 14, n. 2, p. 8
- By:
- Publication type:
- Article
Epidermal Growth Factor Receptor Mutations Detected by Denaturing High-Performance Liquid Chromatography in Nonsmall Cell Lung Cancer.
- Published in:
- Cancer (0008543X), 2010, v. 116, n. 18, p. 4309, doi. 10.1002/cncr.25214
- By:
- Publication type:
- Article
Safety and Efficacy Results of the Advanced Renal Cell Carcinoma Sorafenib Expanded Access Program in North America.
- Published in:
- Cancer (0008543X), 2010, v. 116, n. 5, p. 1272, doi. 10.1002/cncr.24864
- By:
- Publication type:
- Article
Safety and Efficacy of Sorafenib in Elderly Patients Treated in the North American Advanced Renal Cell Carcinoma Sorafenib Expanded Access Program.
- Published in:
- Oncology, 2010, v. 78, n. 5/6, p. 340, doi. 10.1159/000320223
- By:
- Publication type:
- Article